AU8725191A - Pharmaceutical composition containing an ace inhibitor and an inhibitor of thromboxane a2 activity for treating nephropathies - Google Patents

Pharmaceutical composition containing an ace inhibitor and an inhibitor of thromboxane a2 activity for treating nephropathies

Info

Publication number
AU8725191A
AU8725191A AU87251/91A AU8725191A AU8725191A AU 8725191 A AU8725191 A AU 8725191A AU 87251/91 A AU87251/91 A AU 87251/91A AU 8725191 A AU8725191 A AU 8725191A AU 8725191 A AU8725191 A AU 8725191A
Authority
AU
Australia
Prior art keywords
inhibitor
thromboxane
activity
pharmaceutical composition
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU87251/91A
Inventor
Paolo Cozzi
Teresa Micheletti
Patricia Salvati
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Farmitalia Carlo Erba SRL
Carlo Erba SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmitalia Carlo Erba SRL, Carlo Erba SpA filed Critical Farmitalia Carlo Erba SRL
Publication of AU8725191A publication Critical patent/AU8725191A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU87251/91A 1990-10-16 1991-10-16 Pharmaceutical composition containing an ace inhibitor and an inhibitor of thromboxane a2 activity for treating nephropathies Abandoned AU8725191A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT021757A IT9021757A1 (en) 1990-10-16 1990-10-16 PRODUCT FOR THE TREATMENT OF NEPHROPATHIES
IT21757/90 1990-10-16

Publications (1)

Publication Number Publication Date
AU8725191A true AU8725191A (en) 1992-05-20

Family

ID=11186438

Family Applications (1)

Application Number Title Priority Date Filing Date
AU87251/91A Abandoned AU8725191A (en) 1990-10-16 1991-10-16 Pharmaceutical composition containing an ace inhibitor and an inhibitor of thromboxane a2 activity for treating nephropathies

Country Status (9)

Country Link
EP (1) EP0556204A1 (en)
JP (1) JPH06501943A (en)
AU (1) AU8725191A (en)
IE (1) IE913585A1 (en)
IL (1) IL99667A0 (en)
IT (1) IT9021757A1 (en)
PT (1) PT99238A (en)
WO (1) WO1992006713A1 (en)
ZA (1) ZA918038B (en)

Also Published As

Publication number Publication date
WO1992006713A1 (en) 1992-04-30
IT9021757A1 (en) 1992-04-17
IL99667A0 (en) 1992-08-18
ZA918038B (en) 1992-06-24
EP0556204A1 (en) 1993-08-25
IE913585A1 (en) 1992-04-22
JPH06501943A (en) 1994-03-03
IT9021757A0 (en) 1990-10-16
PT99238A (en) 1992-09-30

Similar Documents

Publication Publication Date Title
HUP9801877A3 (en) Medicaments containing tetrahydrofuryl-sulphonamide-derivative as inhibitors of aspartyl-proteases
AU5450194A (en) Application of microsubstrates for materials processing
AU6797094A (en) Cosmetic treatment of substrates
AU617602B2 (en) Film-forming emulsion containing iodine and methods of use
AU693802B2 (en) Agent for transdermal application containing gestoden esters
HUP9601698A3 (en) Pharmaceutical composition of adiabetical activity
HUP0400694A3 (en) Small molecule inhibitors of rotamase enzyme activity and pharmaceutical compositions containing the compounds
ZA933441B (en) Inhibitors of testosterone 5 alpha-reductase activity
AU6587294A (en) Enhancement of transdermal drug delivery using monoalkyl phosphates and other absorption promoters
ZA936964B (en) Pharmaceutical compositions containing derivatives of nomegestrol and their process of manufacture
HUP9702241A3 (en) Use of 2-aminoindan derivatives and pharmaceutical compositions containing them
AU5850894A (en) Novel agents for inhibition of hiv infectivity and use therefor
AU5100393A (en) Diindolo compounds and pharmaceutical compositions containing them
AU6351186A (en) Pharmaceutical composition comprising 1-hydroxy-2-pyridone and method for the treatment of acne
AU1347988A (en) Agent for durable deformation or removal of hair
AU4532893A (en) Antihypercholesterolemic compounds and related pharmaceutical compositions and methods of use
AU4220193A (en) Deazaaminopterins for treatment of inflammation
AU4709593A (en) Use of inhibitors of vacuolar-type H+ atpases
AU6527390A (en) Pharmaceutical compositions for the treatment of ataxy and equilibrium problems
AU4104093A (en) Method and compositions for treatment of pyonecrotic processes
AU8725191A (en) Pharmaceutical composition containing an ace inhibitor and an inhibitor of thromboxane a2 activity for treating nephropathies
AU4573793A (en) N-cycloalkylpiperazine derivatives, methods of obtaining them and pharmaceutical compositions containing them
PL310675A1 (en) Application of ferrocene
AU3149289A (en) Method and agent for inhibiting the binding of human polymorphonuclear leukocytes to endothelium and compositions therefor
AU630938B2 (en) Inhibitors of aminoglycoside nepthrotoxicity